Enzymatic anticancer therapy
Details for Australian Patent Application No. 2008242791 (hide)
International Classifications
Event Publications
26 November 2009 PCT application entered the National Phase
PCT publication WO2008/131163 Priority application(s): WO2008/131163
20 May 2010 Assignment before Grant
Enzon Pharmaceuticals, Inc. The application has been assigned to Defiante Farmaceutica, S.A.
22 March 2012 Assignment before Grant
Defiante Farmaceutica, S.A. The application has been assigned to Sigma-Tau Rare Diseases, S. A.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008242796-Electrically isolating insulated conductor heater
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser